healthcare research

Driving the usefulness of AI in healthcare: IBM Research showcases work at AMIA 2020

Researchers from our IBM Research labs around the world and from IBM Watson Health have contributed a total of 47 workshops, papers, posters and panels that will be presented at AMIA 2020. These contributions cover a wide range of topics but reflect our overarching goal of driving the usefulness of AI in Healthcare.

Continue reading

IBM AI algorithms can read chest X-rays at resident radiologist levels

Our team of researchers based at the IBM Research-Almaden lab in California have been pursuing an ambitious challenge of building machines that can perform a preliminary read of chest X-rays provably at the level of at least entry-level radiologists.

Continue reading

Could AI help clinicians to predict Alzheimer’s disease before it develops?

A new AI model, developed by IBM Research and Pfizer, has used short, non-invasive and standardized speech tests to help predict the eventual onset of Alzheimer’s disease within healthy people with an accuracy of 0.7 and an AUC of 0.74 (area under the curve).

Continue reading

Advancing the Potential of AI in Medical Imaging at MICCAI 2020

I believe one of the most promising areas for AI to make an impact is in the field of medical imaging. Through advancements in AI that allow for more intelligent and accurate analysis of video and still images, there is hope that clinicians will soon be able to widely augment the data and information they […]

Continue reading

In Collaboration with the National Institutes of Health, IBM Research Dives Deep into Biomarkers of Schizophrenia

In collaboration with researchers from Harvard Medical School, Mt. Sinai School of Medicine, Stanford University and the Northern California Institute for Research and Education, IBM Research is undertaking a new research initiative funded by the National Institute of Health.

Continue reading

AI Data Tracker Encourages Scientific Research into COVID-19 Non-Pharmaceutical Interventions

What impact do measures such as shelter-in-place, mask wearing, and social distancing have on the number of COVID-19 cases? How do the COVID-19 quarantine measures that have been implemented by North American countries compare to South American countries? These are just a few questions about the wide range of non-pharmaceutical interventions (NPIs) that have been applied by governments, globally.

Continue reading

IBM Research and the Broad Institute Seek to Unravel the True Risks of Genetic Diseases

In 2019, IBM and the Broad Institute of MIT and Harvard started a multi-year collaborative research program to develop powerful predictive models that can potentially enable clinicians to identify patients at serious risk for cardiovascular disease (1, 2). At the start of our collaboration, we proposed an approach to develop AI-based models that combine and […]

Continue reading

Helping Advance Huntington’s Disease Research by Using AI to Map the Human Brain

In a new study, IBM and CHDI researchers studied the relationship between the pace of subtle cognitive decline in patients before full-fledged symptoms and their brain activity, as shown by a functional MRI. The results demonstrate that measuring the potential progression of HD could eventually be done from a single brain scan, acquired in one visit.

Continue reading

AI Models Predict Breast Cancer with Radiologist-Level Accuracy

Our team of IBM researchers published research in Radiology around a new AI model that can predict the development of malignant breast cancer in patients within the year, at rates comparable to human radiologists.

Continue reading

IBM and Johns Hopkins University School of Medicine Discover Unique, Pathogenic Autoimmune Cells in Type 1 Diabetes

Researchers at JHU and IBM identify new cells involved in the autoimmune attack on insulin-producing cells in type 1 diabetes.

Continue reading

Continuous-Flow Reactor Could Potentially Help Speed Drug Discovery

New continuous-flow approach to chemical synthesis holds promise in accelerating therapeutic discovery for drug-resistant infectious diseases and cancer.

Continue reading

Research Using IBM Cloud and AI Sheds Light on Huntington’s Disease (HD)

New research combining the power of brain modeling, IBM’s AI, and the IBM Cloud sheds light on how brain cells interact in Huntington’s disease.

Continue reading